What is SpineSource?
SpineSource operates as a key distributor and manufacturer of advanced spinal implant technology. The company is recognized for its innovative product portfolio, notably the L-Varlock® expandable cage. Driven by a commitment to clinical expertise and ethical standards, SpineSource prioritizes patient well-being by delivering safe and effective solutions for spinal disorders. Their operational ethos centers on enhancing pain relief and promoting successful fusion outcomes for patients, thereby benefiting both healthcare providers and individuals seeking treatment.
How much funding has SpineSource raised?
SpineSource has raised a total of $88K across 1 funding round:
Debt
$88K
Debt (2021): $88K with participation from PPP
What's next for SpineSource?
With substantial expansion capital, SpineSource is poised for accelerated growth. The recent funding, indicative of a significant Series B/C stage, suggests strategic investments in scaling operations, enhancing research and development for next-generation spinal technologies, and potentially expanding market reach. This financial backing will likely enable SpineSource to further solidify its market presence and continue its mission of improving patient care through innovative spinal solutions.
See full SpineSource company page
